Do dollars dictate dissent? Are agendas altered as advised? Government statements related to these questions - specifically, the foreign funding of non-government organisations (NGOs) involved in the protests against nuclear power at Kudankulam - generated much discussion. The uproar is over, and Kudankulam will soon be operational. However, many wider issues remain, and these merit consideration. Among these, two significant ones are the role of NGOs - or, more specifically, civil...
More »SEARCH RESULT
How TB is silently killing India’s mothers by Satyavrat Chaturvedi
According to the WHO, TB is the third leading cause of death for women aged 15-44 worldwide. When did we last consider TB as one of India’s biggest health problems? To refresh memories, here are a few forgotten facts about TB in India: one of the leading causes of death in India, TB kills one person every two minutes and 750 people every day. The direct and indirect annual costs of...
More »Need for new TB drugs
-The Hindu Public sector participation in discovering, developing and making a drug available at affordable prices may be the only way to find new cures for diseases like TB, says Pof Samir Brahmachari on the occasion of World Tuberculosis Day Tuberculosis (TB), a raging problem in Europe and Americas till early 20 century, now predominantly affects the developing world where it continues to be a major health problem and is making in...
More »SC slams govt's 'casual' approach on gay sex
-The Times of India The Supreme Court on Tuesday criticized the Centre's "casual approach" during the hearing on appeals challenging a Delhi High Court verdict diluting Section 377 of the Indian Penal Code to decriminalize consensual gay sex between consenting adults in private. The ministries of home affairs and health had opposed dilution of Section 377 before the HC but accepted the verdict and did not appeal against it in the apex...
More »India patent bypass delivers life-saving blow against cancer by Raja Murthy
India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...
More »